Ann: Investor Presentation on Zoetis exclusive global license, page-15

I agree wholeheartedly. It’s been a rough few days but the worldwide need for Detach had not changed. It is unnerving such a drop and I get the little thought bubble of occasional doubt but I truly believe in the commercialisation of this product.

It’s interesting times, I’ve been shaken by a few investments one for example AXP where the product is brilliant but the execution and commercialisation poor. It’s frustrating when what they offer the world of health is dazzling.

Let’s hope the deal with Zoetis and change of leadership reinvigorates Anantara.

Thank you Mel for getting Anatara this far and good luck with all future endeavours